Michelle Cox
Papers
1
Total Citations
47
H-Index
1
About
Dr. Michelle Cox is a pioneering urologic surgeon whose work has transformed the management of testicular cancer, particularly through the application of minimally invasive techniques in complex post-chemotherapy settings. Her primary research focuses on robotic retroperitoneal lymph node dissection (R-RPLND), a technically demanding procedure for removing residual masses after chemotherapy. Dr. Cox’s landmark study, “Post-Chemotherapy Robotic Retroperitoneal Lymph Node Dissection: Institutional Experience,” with 47 citations, provided critical early evidence that R-RPLND is both feasible and safe, challenging the prevailing reliance on open surgery. By meticulously documenting outcomes in a cohort of 12 patients, she demonstrated reduced morbidity without compromising oncologic control, establishing a new benchmark for surgical care in this high-stakes arena. Her work has directly influenced clinical guidelines and inspired a generation of surgeons to adopt robotic approaches for testicular cancer. Dr. Cox’s contributions are not merely technical; they represent a paradigm shift toward less invasive, patient-centered care in urologic oncology, cementing her reputation as a leader in the field.
Research Focus
Key Achievements
Top Papers
- 1